Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0111) | |||||
---|---|---|---|---|---|
DME Name | Ecto-5'-nucleotidase (NT5E), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 3.1.3.5 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2B30 Lymphoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Lymphoma | Significant hypermethylation | |||
Interaction Name | DNMT-NT5E interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 1.57E-23; delta-beta: 4.91E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the NT5E gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Ecto-5'-nucleotidase. As a result, the interaction between DNMT and NT5E can significantly affect the drug-metabolizing process of Ecto-5'-nucleotidase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2B90 Colorectal cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Transcription-factor regulation | |||||
ARNT-interacting protein (HIF1A) | Colorectal cancer | Activation | |||
Uniprot ID | |||||
Interaction Name | HIF1A-NT5E interaction | [1] | |||
Studied Cell Lines | T84 cell line | ||||
Ensembl ID | |||||
Description | ARNT-interacting protein (HIF1A) is reported to activate the transcription of NT5E gene, which leads to an increased expression of the drug-metabolizing enzyme Ecto-5'-nucleotidase. As a result, the interaction between HIF1A and NT5E can activate the drug-metabolizing process of Ecto-5'-nucleotidase. | ||||
ICD-11: 2C25 Lung cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Non-coding RNA regulation | |||||
hsa-miR-30a-5p | Lung cancer | Suppression | |||
miRBase ID | |||||
Interaction Name | hsa-miR-30a-5p--NT5E regulation | [2] | |||
Studied Cell Lines | A549 and H226 cell lines | ||||
Description | hsa-miR-30a-5p is reported to suppress NT5E mRNA translation by binding to the 3' untranslated region (3'UTR) of NT5E mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Ecto-5'-nucleotidase. | ||||
ICD-11: 2C60 Breast cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Histone modification | |||||
Histone deacetylases (HDACs) | Breast cancer | Repression | |||
Uniprot ID | |||||
Interaction Name | HDACs-NT5E interaction | [3] | |||
Studied Cell Lines | Human breast cancer cell lines | ||||
Description | Histone deacetylases (HDACs) are reported to deacetylate the NT5E gene and thereby repress the transcriptional activity of the drug-metabolizing enzyme Ecto-5'-nucleotidase. As a result, the interaction between HDACs and NT5E can inhibit the drug-metabolizing process of Ecto-5'-nucleotidase. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.